What Is Sustanon? Composition, Medical Uses, Dosage, Side Effects, and How It Compares to Other TRT Options

Sustanon is one of the most recognised testosterone injection formulations in the world — and one of the most misunderstood. Originally developed for clinical Testosterone Replacement Therapy, it is distinguished by its unique blend of four testosterone esters that produce both a rapid initial rise in testosterone and a sustained effect lasting several weeks. It is widely prescribed in the UK and Europe for confirmed hypogonadism, is available in some other markets, but is not approved for use in the United States, where testosterone cypionate and enanthate are the standard TRT injections. This guide covers what Sustanon is, its precise composition, how it works, its approved and off-label uses, the correct dosage and monitoring protocol, side effects and who should avoid it, and how it compares to other testosterone injections.

What Is Sustanon and Where Is It Available?

Sustanon is a brand-name injectable testosterone product manufactured by Organon. It is an oil-based intramuscular injection classified as an anabolic androgenic steroid (AAS) — specifically, a combination of four testosterone esters suspended in arachis (peanut) oil with benzyl alcohol as a preservative.

Sustanon comes in two main formulations:

• Sustanon 250: The most widely used formulation. Contains 250 mg of testosterone as a blend of four esters per 1 ml ampoule.
• Sustanon 100: A lower-concentration formulation (100 mg per ml) that was historically used in some markets, less commonly prescribed today.

Regional availability — an important distinction

Sustanon 250 is available by prescription in the UK, Europe, Australia, South Africa, and many other markets. It is not approved for use in the United States. US men receiving Testosterone Replacement Therapy are typically prescribed testosterone cypionate or testosterone enanthate instead. Almost all TRT literature from the US focuses on these single-ester formulations, which is why some men researching Sustanon in a US context may find limited domestic prescribing guidance.

In the UK, Sustanon 250 is one of the most commonly prescribed TRT injections and is available on the NHS and through private men’s health clinics.

Sustanon 250 Composition: The Four Esters and What Each Does

What makes Sustanon 250 unique among testosterone injections is its multi-ester formulation. Each 1 ml ampoule of Sustanon 250 contains four testosterone esters at specific doses:

• Testosterone propionate 30 mg: The shortest-acting ester. Begins releasing testosterone within 24 to 48 hours of injection. This is what provides the rapid initial testosterone rise — the ‘fast-acting’ component that distinguishes Sustanon from longer-acting single-ester formulations.
• Testosterone phenylpropionate 60 mg: An intermediate ester. Maintains testosterone levels in the days following the propionate peak, bridging toward the slower-release components.
• Testosterone isocaproate 60 mg: A slower-release intermediate ester. Continues releasing testosterone over approximately 1 to 2 weeks, extending the hormonal effect.
• Testosterone decanoate 100 mg: The longest-acting ester. Provides sustained testosterone release for 2 to 3 weeks, forming the ‘long-tail’ of the injection’s pharmacokinetic profile.

Together these four esters produce a pharmacokinetic profile characterised by a rapid initial peak from propionate, a sustained plateau from the two intermediate esters, and a long tail from decanoate — all from a single injection.

Peanut allergy warning:  Sustanon 250 contains arachis (peanut) oil and benzyl alcohol. Men with a known peanut or soya allergy must not use Sustanon 250 and should inform their prescriber before treatment. Testosterone cypionate (cottonseed or olive oil) or testosterone enanthate (sesame oil) are available as alternatives. Always disclose all known allergies before any injectable testosterone is prescribed.

How Sustanon Works in the Body

After intramuscular injection, Sustanon’s four esters are gradually cleaved from the testosterone molecule at different rates by tissue esterases. As each ester is cleaved, free testosterone is released into the bloodstream.

Free testosterone then circulates and binds to androgen receptors throughout the body — in muscle, bone, the brain, the reproductive system, and the skin. This androgen receptor binding replicates the action of endogenous testosterone, restoring the hormonal signals that drive the physiological effects testosterone normally governs.

The multi-ester design means testosterone is entering the bloodstream continuously across a spectrum of timepoints — propionate releasing in 24 to 48 hours, the intermediates across the first 2 weeks, decanoate sustaining the level into the third week. The intention is to avoid the sharp peak-and-trough pattern of a single short-acting ester while still providing a rapid initial rise.

In practice, Sustanon still produces some hormonal fluctuation across the dosing interval — it does not produce perfectly flat testosterone levels. This is discussed further in the comparison section below.

Medical Uses of Sustanon

Male Hypogonadism

The primary approved indication is confirmed testosterone deficiency — either primary hypogonadism (failure of testicular production) or secondary hypogonadism (insufficient hypothalamic-pituitary stimulation of the testes). Diagnosis requires confirmed testosterone below the clinical threshold (generally below 300 ng/dL or 10.4 nmol/L) on at least two morning blood tests, alongside clinical symptoms.

Delayed puberty in adolescent males

Sustanon may be used in carefully selected adolescent males with confirmed testosterone deficiency causing delayed pubertal development. Dosing in this context is lower and closely supervised, with careful monitoring of bone age and growth to avoid premature epiphyseal closure.

Long-term Testosterone Replacement Therapy

In adult men with confirmed hypogonadism, Sustanon provides ongoing hormonal replacement to maintain testosterone in the normal physiological range. The standard dosing interval of every 3 to 4 weeks makes it convenient for long-term management in men who prefer less frequent injections than weekly cypionate or enanthate protocols.

Off-Label Use: What You Should Know

Sustanon is used off-label, particularly in bodybuilding and athletic contexts, for its anabolic effects on muscle mass, strength, and recovery. It is important to be explicit about the evidence and the risks.

Sustanon’s anabolic effects on lean mass and strength in supraphysiological (above-normal) doses are documented in the research literature. However, using Sustanon for performance enhancement rather than confirmed medical need significantly increases the risk of serious adverse effects — including permanent hormonal suppression, cardiovascular disease, polycythaemia, liver dysfunction, and psychological effects. It also violates anti-doping regulations in virtually all competitive sports.

Additionally, Sustanon obtained without a prescription — through online black markets, particularly in markets where it is not approved — carries the additional risk of counterfeit or contaminated products. In countries where Sustanon is approved, it is a prescription-only controlled substance.

Sustanon Dosage and Administration

Standard TRT dosage

For adult men receiving Testosterone Replacement Therapy for confirmed hypogonadism, the standard starting dose is:

• Sustanon 250: 250 mg (one ampoule) administered every 3 to 4 weeks by deep intramuscular injection
• Some prescribers adjust to every 2 to 3 weeks if the patient experiences significant symptoms in the final week before the next injection — a common ‘trough’ phenomenon
• More frequent smaller doses (e.g. 125 mg every 2 weeks) are sometimes used to reduce peaks and troughs

Dosage adjustments are made based on blood test results — both total testosterone and haematocrit — rather than on symptoms alone. Never self-adjust the dose.

Administration

• Sustanon 250 is administered by deep intramuscular (IM) injection — most commonly into the gluteal (buttock) muscle or vastus lateralis (outer thigh)
• It is NOT suitable for subcutaneous (under-the-skin) injection — the benzyl alcohol content at the concentration in Sustanon 250 makes it unsuitable for SubQ use, unlike testosterone cypionate which can be safely administered subcutaneously
• The injection should be given by a trained clinician, or self-administered under proper guidance and training
• Rotate injection sites between left and right gluteal/thigh muscles to prevent localised soreness and scar tissue formation
• Allow the ampoule to reach room temperature before injection — cold oil is more viscous and harder to inject

Monitoring While on Sustanon

Regular blood tests are mandatory for anyone on Sustanon. The original article does not cover this section — it is one of the most practically important aspects of safe TRT management.

• Before starting: Total testosterone (morning blood test), haematocrit/full blood count, PSA (in men over 40), liver function, lipid profile, blood pressure.
• At 3 months: Total testosterone (timed correctly — mid-interval, approximately 10 to 14 days after injection for standard 3 to 4 week dosing), haematocrit, symptoms review.
• At 6 months: Full review including testosterone, haematocrit, PSA, lipids, blood pressure.
• Annually thereafter: Full monitoring panel as above. More frequent monitoring if haematocrit is elevated or any concerning symptoms arise.

The most important safety metric to monitor is haematocrit — the proportion of red blood cells in the blood. Testosterone stimulates red blood cell production. If haematocrit rises above approximately 52 to 54%, the risk of blood clot, stroke, and cardiovascular events increases, and dose reduction, more frequent smaller injections, or therapeutic phlebotomy may be required.

Aromatisation, Oestrogen, and Side Effect Management

Testosterone is partially converted (aromatised) to oestradiol (oestrogen) by the aromatase enzyme in fat tissue. This is a normal physiological process — men need some oestrogen for bone health, cardiovascular function, and mood. However, when testosterone levels are raised by exogenous testosterone including Sustanon, aromatisation increases proportionally, potentially raising oestradiol to levels that cause side effects.

• Signs of elevated oestradiol: Gynaecomastia (breast tissue growth or tenderness), excessive fluid retention, mood changes, and reduced libido.
• Aromatase inhibitors (AIs): Anastrozole and exemestane are sometimes prescribed to men on TRT when oestradiol is significantly elevated. However, over-suppression of oestrogen carries its own risks (joint pain, reduced libido, impaired cardiovascular health), and many clinicians now avoid routine AI use, preferring to adjust testosterone dose instead.
• The Sustanon-specific consideration: The propionate ester in Sustanon produces a rapid testosterone peak immediately after injection. This sharp peak can drive more acute aromatisation than single long-acting esters, potentially causing more oestrogen-related side effects around injection day. Some men find more frequent smaller doses reduce this.

Side Effects of Sustanon

Common side effects

• Injection site reactions — pain, redness, swelling, or bruising at the injection site
• Acne and oily skin — from increased androgen stimulation of sebaceous glands
• Fluid retention — ankles, feet, or face, particularly in early treatment
• Gynaecomastia — breast tissue growth or tenderness, related to oestrogen elevation
• Changes in libido — may increase initially, then fluctuate with hormonal changes
• Mood changes — irritability, mood swings, particularly around injection peaks and troughs
• Erythrocytosis (elevated red blood cell count / haematocrit) — requires monitoring
• Male pattern hair loss acceleration — in men genetically predisposed

Serious side effects requiring immediate medical attention

• Priapism: A painful, prolonged erection lasting more than 4 hours. A urological emergency — seek emergency care immediately.
• Severe allergic reaction: Including anaphylaxis — rare but possible, particularly in men with peanut allergy who have not disclosed it before treatment.
• Blood clot (thromboembolism): Deep vein thrombosis or pulmonary embolism. Risk is increased by high haematocrit. Symptoms include leg pain, swelling, chest pain, or shortness of breath.
• Liver dysfunction: Rare with injectable testosterone at therapeutic doses but possible with very high off-label doses.
• Cardiovascular events: Elevated cardiovascular risk in men with pre-existing cardiovascular disease or very high haematocrit. Symptoms of heart attack or stroke require emergency care.

Who Should Not Use Sustanon

• Men with confirmed or suspected prostate cancer or male breast cancer
• Men wishing to father children in the near term — see the fertility section below
• Men with a history of, or high risk for, blood clots or cardiovascular events
• Men with severe heart, liver, or kidney disease
• Men with uncontrolled high blood pressure
• Men with untreated Obstructive Sleep Apnoea
• Men with elevated haematocrit or polycythaemia
• Men with a known allergy to peanuts, soya, or any ingredient in Sustanon (including benzyl alcohol)
• Women — particularly those who are pregnant or breastfeeding
• Children under 18 (except under specialist supervision for documented delayed puberty)

Sustanon vs Testosterone Cypionate vs Enanthate: How They Compare

This comparison is absent from the original article and is one of the most searched questions about Sustanon. Understanding the differences helps men in markets where all options are available make an informed conversation with their prescriber.

Sustanon 250

• Multi-ester blend — four esters producing rapid onset and long duration
• Standard injection interval: every 3 to 4 weeks (sometimes every 2 to 3 weeks for trough management)
• Produces initial testosterone peak from propionate component — can drive acute aromatisation
• NOT suitable for subcutaneous injection (benzyl alcohol content)
• Carrier oil: arachis (peanut) oil — contraindicated in peanut/soya allergy
• Available: UK, Europe, Australia, and many other markets; NOT approved in the US

Testosterone Cypionate

• Single ester — testosterone cypionate with approximately 8-day half-life
• Standard injection interval: weekly or every 10 days for stable levels; sometimes fortnightly
• More predictable, uniform release pattern — easier to titrate
• CAN be administered subcutaneously — preferred by many for self-injection
• Carrier oil: cottonseed or olive oil — suitable for men with peanut allergy
• Available: US, Canada, and many other markets; the standard US TRT injection

Testosterone Enanthate

• Single ester — testosterone enanthate with approximately 4.5-day half-life
• Standard injection interval: weekly or twice-weekly
• Very similar to cypionate; main practical difference is carrier oil (sesame)
• Widely used in Europe and the US; often prescribed when cypionate is unavailable

Which is ‘better’ depends entirely on individual circumstances: availability in your region, injection frequency preference, allergy status, and whether subcutaneous self-injection is desired. All three are effective at restoring testosterone when properly dosed and monitored.

Fertility: A Critical Point the Original Article Gets Wrong

The original FAQ states: ‘Sustanon can improve sperm production in men with low testosterone due to hypogonadism.’ This is factually incorrect and must be corrected.

Like all forms of exogenous testosterone, Sustanon suppresses sperm production — it does not improve it. The mechanism is as follows: exogenous testosterone suppresses the production of Luteinising Hormone (LH) and Follicle-Stimulating Hormone (FSH) by the pituitary gland. These are the hormones that signal the testes to produce both testosterone and sperm. Without LH and FSH stimulation, the testes reduce their function — leading to testicular atrophy and significantly reduced or absent sperm production, often falling to zero with long-term use.

This is one of the most clinically important facts about TRT for men of reproductive age. Sustanon — like testosterone cypionate, enanthate, or any other exogenous testosterone — is not a fertility treatment. Men who wish to conceive should discuss alternatives with a urologist or reproductive endocrinologist before starting any TRT, including Sustanon. Options such as hCG (human Chorionic Gonadotrophin) or clomiphene can support sperm production while managing testosterone levels.

Conclusion

Sustanon is a clinically well-established testosterone injection formulation that offers a practical balance of rapid onset and extended duration through its unique four-ester composition. When prescribed for confirmed hypogonadism and managed with appropriate monitoring — blood tests at 3, 6, and 12 months, attention to haematocrit, PSA, and oestradiol — it is an effective and well-tolerated TRT option for eligible men.

Its limitations compared to single-ester formulations include the inability to use it subcutaneously (due to benzyl alcohol content), the propionate-driven acute testosterone peak that can drive oestrogen elevation, and its limited availability in markets outside the UK and Europe. US-based men are unlikely to be prescribed Sustanon; testosterone cypionate is the standard US TRT injection.

As with all testosterone therapy, Sustanon is a prescription-only medicine requiring confirmed clinical need and ongoing medical supervision. Off-label use for performance enhancement carries serious and potentially irreversible health risks. Men considering Sustanon for the first time should begin with a confirmed testosterone blood test and a conversation with a qualified clinician.

Frequently Asked Questions

1. How long does Sustanon stay in your system?

Sustanon 250 can maintain detectable testosterone levels for 3 to 4 weeks due to its long-acting decanoate ester. Complete clearance of all esters from the body typically takes 6 to 8 weeks after the final injection, depending on individual metabolism, dose, and duration of treatment. This extended clearance window is relevant both for monitoring (blood tests should be timed mid-interval) and for anti-doping testing purposes.

2. How long does Sustanon take to work?

The propionate ester begins releasing testosterone within 24 to 48 hours of injection, so some improvement in energy and mood may be noticed within the first few days. Full therapeutic effects — including improvements in libido, muscle strength, and overall sense of well-being — typically become apparent within 3 to 6 weeks of consistent treatment, once stable testosterone levels are established. Individual response times vary.

3. Does Sustanon increase or decrease sperm count?

Sustanon decreases sperm production — it does not increase it. Like all exogenous testosterone, Sustanon suppresses LH and FSH from the pituitary gland, which are the signals that drive testicular sperm production. This typically leads to significantly reduced or absent sperm production with sustained use, and testicular atrophy. Men wishing to conceive should not start Sustanon without first discussing fertility preservation options (such as hCG or sperm banking) with a reproductive specialist.

4. Can women use Sustanon?

Sustanon is not approved or recommended for use in women for general purposes due to the risk of virilisation — masculinising effects including deepening of the voice, increased body hair, clitoral enlargement, and hormonal disruption. It is contraindicated during pregnancy due to the risk of virilisation of a female foetus. In certain specific clinical contexts, testosterone therapy may be considered for women under specialist supervision, but Sustanon 250 in its standard formulation is not the appropriate product.

5. Is Sustanon safe for men with thyroid disorders?

Sustanon does not directly affect thyroid function. However, changes in testosterone levels can influence metabolism, energy levels, and the way thyroid hormone interacts with other hormones, potentially affecting how thyroid medication requirements change. Men with thyroid disorders using Sustanon should be monitored by both their prescribing doctor and their endocrinologist, with periodic thyroid function tests alongside the standard TRT monitoring schedule.

Citations

1. NPS MedicineWise (Australia). Sustanon 250 injection — product information. https://www.nps.org.au/medicine-finder/sustanon-250-injection
2. Medsafe New Zealand. Sustanon consumer medicine information. https://www.medsafe.govt.nz/consumers/cmi/s/Sustanon.pdf
3. Balance My Hormones. The Truth On Sustanon Injections And Side Effects (April 2025). https://balancemyhormones.co.uk/sustanon-injections-side-effects/
4. Voy Health. Sustanon 250 injection for TRT: Uses, half-life & side effects. https://www.joinvoy.com/blog/sustanon-injection
5. Testosterone Cypionate vs Sustanon: Blend Comparison. https://testodepot.com/cypionate-vs-sustanon/
6. Testosterone Cypionate vs Sustanon — A Comparison for TRT. https://medxdrg.com/which-is-better-testosterone-cypionate-or-sustanon-a-comparison-for-trt
7. European Medicines Agency. Sustanon 250 — summary of product characteristics. https://www.ema.europa.eu/en/medicines/human/EPAR/sustanon

This article is for general informational purposes only and does not constitute medical advice. Sustanon is a prescription-only controlled substance. Always consult a qualified healthcare provider before starting any testosterone therapy. Do not use Sustanon without a valid prescription and ongoing medical supervision.